Biotech Co. Slapped With Stock-Drop Suit Over Patent Failure
A biotechnology firm's executives misled investors about patent rejections for its star product, which sent its stock into free fall when the news went public, according to a derivative suit filed...To view the full article, register now.
Already a subscriber? Click here to view full article